CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
So Heun Lee, Dae Wook Hwang, Changhoon Yoo, Kyu-pyo Kim, Sora Kang, Jae Ho Jeong, Dongwook Oh, Tae Jun Song, Sang Soo Lee, Do Hyun Park, Dong Wan Seo, Jin-hong Park, Ki Byung Song, Jae Hoon Lee, Woohyung Lee, Yejong Park, Bong Jun Kwak, Heung-Moon Chang, Baek-Yeol Ryoo, Song Cheol Kim
Cancer Research and Treatment. 2023;55(3):956-968.   Published online 2023 February 27    DOI: https://doi.org/10.4143/crt.2022.409

Excel Download

Clinical relevance of adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma who underwent surgery following neoadjuvant modified FOLFIRINOX
International Journal of Surgery. 2022;100:106535   Crossref logo
Link1 Link2

Important CT and histopathological findings for recurrence and overall survival in patients with pancreatic ductal adenocarcinoma who underwent surgery after neoadjuvant FOLFIRINOX
European Radiology. 2020;31(6):3616-3626   Crossref logo
Link1 Link2 Link3

Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
Cancer Research and Treatment. 2023;55(3):956-968   Crossref logo
Link1 Link2 Link3

Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: A retrospective cohort study
International Journal of Surgery. 2023;   Crossref logo
Link1

Adjuvant Chemotherapy Associated with Survival Benefit Following Neoadjuvant Chemotherapy and Pancreatectomy for Pancreatic Ductal Adenocarcinoma: A Population-Based Cohort Study
Annals of Surgical Oncology. 2021;28(11):6790-6802   Crossref logo
Link1 Link2 Link3

MO6-5 Clinical relevance of adjuvant chemotherapy in patients who underwent surgery following neoadjuvant modified FOLFIRINOX
Annals of Oncology. 2022;33:S485   Crossref logo
Link1 Link2

The Benefit of Adjuvant Chemotherapy Following Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma Depends on Response to Neoadjuvant Therapy
HPB. 2022;24:S8   Crossref logo
Link1 Link2

Adjuvant radiotherapy may not confer survival benefit for cT1-2N1M0 breast cancer patients who undergo surgical treatment following neoadjuvant chemotherapy: an analysis based on SEER
. 2023;   Crossref logo
Link1 Link2

HPB P30 What is the Impact of Neoadjuvant Chemotherapy on Survival after Palliative Procedures for Pancreatic Ductal Adenocarcinoma?
British Journal of Surgery. 2022;109(Supplement_9):   Crossref logo
Link1 Link2

A nomogram for predicting overall survival of patients with pancreatic ductal adenocarcinoma (PDAC) who underwent radical pancreatoduodenectomy(R0)
. 2022;   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.